Publications by authors named "Reid Rubsamen"

Claim this Profile
B
Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine.
Paul E Harris, Scott Burkholz, Charles V Herst, Reid M Rubsamen

Vaccines (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges.
Reid M Rubsamen, Andrew E Sloan

Front Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response.
Angelina Sverchkova, Scott Burkholz, Reid Rubsamen, Richard Stratford, Trevor Clancy

BMC Med Genomics· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications.
Sharon Wright, Scott R Burkholz, Cathy Zelinsky, Connor Wittman, Richard T Carback, Reid M Rubsamen

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study.
Scott R Burkholz, Charles V Herst, Richard T Carback, Paul E Harris, Reid M Rubsamen

Vaccines (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans.
Scott Burkholz, Suman Pokhrel, Benjamin R Kraemer, Daria Mochly-Rosen, Richard T Carback, Reid Rubsamen

Infect Genet Evol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.
Paul E Harris, Trevor Brasel, Christopher Massey, C V Herst, Scott Burkholz, Reid M Rubsamen

Vaccines (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome.
Reid Rubsamen, Scott Burkholz, Christopher Massey, Trevor Brasel, Tom Hodge

Front Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling.
Edecio Cunha-Neto, Daniela S Rosa, Paul E Harris, Tim Olson, Alex Morrow, Reid Martin Rubsamen

Front Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the AERx pulmonary delivery system for systemic delivery of a poorly soluble selective D-1 agonist, ABT-431.
Franklin W Okumu, Rai-Yun Lee, James D Blanchard, Anthony Queirolo, Christine M Woods, Reid Rubsamen

Pharm Res· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis